FDA Approves First New Drug in 20 Years for Sickle Cell - NECN
National & International News
The day’s top national and international news

FDA Approves First New Drug in 20 Years for Sickle Cell

In a study, the new drug, Endari, cut the number of pain crises and dangerous chest complications, and reduced hospitalizations and the need for transfusions

    processing...

    NEWSLETTERS

    New Surgery Empowers Breast Cancer Patients
    ASSOCIATED PRESS
    In this March 7, 2007 file photo, a patient is given an injection for pain relief by a nurse at the Sickle Cell Center in Truman Medical Center, Wednesday, March 7, 2007 in Kansas City, Mo. Pain management is vital in the care of patients suffering from Sickle Cell disease.

    The U.S. Food and Drug Administration has approved the first drug in nearly 20 years for sickle cell, an inherited disease in which abnormally shaped red blood cells can't properly carry oxygen throughout the body, which can cause severe pain and organ damage.

    About 100,000 people in the U.S., mostly blacks, have the disorder and about 275,000 babies are born with it each year worldwide.

    In a study, the new drug, Endari, cut the number of pain crises and dangerous chest complications, and reduced hospitalizations and the need for transfusions.

    It is made by a California company, Emmaus Medical Inc., and approved for adults and children 5 and older.

    Colorado Man Charged With Five Counts of Murder in Deaths of Wife and Daughters

    [NATL] Colorado Man Charged With Five Counts of Murder in Deaths of Wife and Daughters

    Christopher Lee Watts was charged with five counts of murder Monday for the deaths of his wife Shanann Watts and their two daughters Bella and Celeste. Watts had initially pleaded publicly that his wife and daughters had gone missing. Their bodies were discovered on the property of the oil and natural gas company Watts worked for. The D.A. said that it's "too early" to discuss whether prosecutors would seek the death penalty.

    (Published Monday, Aug. 20, 2018)